What is Tradjenta?

Category: Prescription Drugs

true

Generic name: Linagliptin

Tradjenta® is a brand name for the medication linagliptan, an oral antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 4

Commonly reported side effects and conditions associated with Tradjenta

Side effect Patients

Dosages

Based on patients currently taking Tradjenta

Dosage Patients
5 mg daily 3
1 tablet(s) daily 1
5 g daily 1
300 mg daily 1

Duration

Currently taking Tradjenta

Duration Patients
1 - 2 years 1
2 - 5 years 5
Adherence
Adherence Evaluations
Always 4
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 4
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 1

What people switch to and from

Patients started taking Tradjenta after stopping:

Treatment Patients
Sitagliptin (Januvia) 2
Canagliflozin (Invokana) 1
Exenatide (Byetta) 1
Glimepiride (Amaryl) 1
Metformin (Glucophage) 1

Patients stopped taking Tradjenta and switched to:

Treatment Patients
Sitagliptin (Januvia) 1
Last updated:
There are no evaluations for Tradjenta.